These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

77 related articles for article (PubMed ID: 365796)

  • 1. Influence of chenodeoxycholic acid on serum triglycerides in patients with primary hypertriglyceridemia.
    Camarri E; Fici F; Marcolongo R
    Int J Clin Pharmacol Biopharm; 1978 Nov; 16(11):523-6. PubMed ID: 365796
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Hypotriglyceridemic effect of chenodeoxycholic acid after a short time of administration.
    Camarri E; Marcolongo R; Fici F
    Int J Clin Pharmacol Biopharm; 1978 Nov; 16(11):527-8. PubMed ID: 365797
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The hypotriglyceridemic effect of chenodeoxycholic acid in type IV hyperlipemia.
    Camarri E; Marcolongo R; Zaccherotti L; Marini G
    Biomedicine; 1978 Oct; 29(6):193-8. PubMed ID: 216433
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The effect of chenodeoxycholic acid (CDCA) on cholesterol absorption.
    Ponz de Leon M; Carulli N; Loria P; Iori R; Zironi F
    Gastroenterology; 1979 Aug; 77(2):223-30. PubMed ID: 447035
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Triglyceride-lowering effect of chenodeoxycholic acid in patients with endogenous hypertriglyceridaemia.
    Miller NE; Nestel PJ
    Lancet; 1974 Oct; 2(7886):929-31. PubMed ID: 4138590
    [No Abstract]   [Full Text] [Related]  

  • 6. Chenodeoxycholic acid and ursodeoxycholic acid effects in endogenous hypertriglyceridemias. A controlled double-blind trial.
    Carulli N; Ponz de Leon M; Podda M; Zuin M; Strata A; Frigerio G; Digrisolo A
    J Clin Pharmacol; 1981 Oct; 21(10):436-42. PubMed ID: 7031100
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Dissolution of gallstones by chenodeoxycholic acid].
    Brändli HH; Hefti ML; Blum AL
    Schweiz Med Wochenschr; 1977 Dec; 107(48):1770-3. PubMed ID: 337470
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Influence of the conservative cholelitholytic therapy using chenodesoxycholic acid (CDC) on cholesterol and triglycerides in the blood of patients with gall stones].
    Caspary WF; Kattermann R
    Z Gastroenterol; 1975 Nov; 13(7):644-7. PubMed ID: 820098
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Comparative efficacy and side effects of ursodeoxycholic and chenodeoxycholic acids in dissolving gallstones. A double-blind controlled study.
    Fromm H; Roat JW; Gonzalez V; Sarva RP; Farivar S
    Gastroenterology; 1983 Dec; 85(6):1257-64. PubMed ID: 6354826
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Results and prospects of therapy of type IV dyslipidemia with chenic acid].
    Camarri E; Marcolongo R; Marini G; Zaccherotti L
    Minerva Med; 1978 May; 69(23):1561-74. PubMed ID: 210428
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Cholesterol kinetics in patients with cholesterol gallstones before and during chenodeoxycholic acid treatment.
    Pedersen L; Arnfred T; Thaysen EH
    Scand J Gastroenterol; 1974 Nov; 9(8):787-91. PubMed ID: 4610716
    [No Abstract]   [Full Text] [Related]  

  • 12. [Positive effects of chenodeoxycholic acid (CDCA) on the biohumoral clinical aspect of cholesterin calculosis of the gallbladder].
    Corazza GR; Simeone E; Di Giammarco AM; Ciccarelli R; Tenaglia G
    Minerva Med; 1978 Mar; 69(12):758-61. PubMed ID: 643217
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Acipimox (Olbetam) as a secondary hypolipemic agent in combined hypertriglyceridemia and hyperlipidemia].
    Yeshurun D; Hamood H; Morad N; Naschitz J
    Harefuah; 2000 Apr; 138(8):650-3, 710. PubMed ID: 10883206
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Study on the rapid effects of SAMe in primary and secondary triglyceridemias].
    Consolo F; Arrigo F; Tommaso GD; Trifirò A
    Minerva Med; 1977 Apr; 68(19):1257-61. PubMed ID: 854226
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effects of treatment with deoxycholic acid and chenodeoxycholic acid on the hepatic synthesis of cholesterol and bile acids in healthy subjects.
    Einarsson C; Hillebrant CG; Axelson M
    Hepatology; 2001 May; 33(5):1189-93. PubMed ID: 11343248
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Treatment of choledocholithiasis with oral chenodeoxycholic acid.
    Sue SO; Taub M; Pearlman BJ; Marks JW; Bonorris GG; Schoenfield LJ
    Surgery; 1981 Jul; 90(1):32-4. PubMed ID: 7017991
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Treatment of primitive hyperlipidemias with a tetralin derivative].
    Fellin R; Fedele D; Bagnariol G; Pagnan A; Crepaldi G
    G Ital Cardiol; 1972; 2(6):863-70. PubMed ID: 4564549
    [No Abstract]   [Full Text] [Related]  

  • 18. [In vivo dissolving of gall-stones: the effect of chenodeoxycholic acid. (author's transl)].
    Fromm H; Eschler A; Töllner D; Canzler H; Schmidt FW
    Dtsch Med Wochenschr; 1975 Aug; 100(32):1619-24. PubMed ID: 170051
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Light and electron microscopy of human liver before and during chenodeoxycholic acid therapy.
    Hartmann W; Paulini K; Goebell H
    Hepatogastroenterology; 1980 Apr; 27(2):91-8. PubMed ID: 7216131
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Effect of chenodeoxycholic acid on cholesterol and triglyceride metabolism].
    Begemann F
    Z Gastroenterol Verh; 1976; (9):42-7. PubMed ID: 64084
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 4.